Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (241-250 of 271) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 18, 2006
Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligandsMasahiko Kainuma, Jun-ichi Kasuga, Shinnosuke Hosoda, et al.
The European Journal of Neuroscience|April 3, 2003
A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insultsTakako Niikura, Yuichi Hashimoto, Hirohisa Tajima, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 4, 2005
Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivoTomohiro Chiba, Marina Yamada, Yuichi Hashimoto, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationshipMasao Ohashi, Takuji Oyama, Izumi Nakagome, et al.
Neuroscience Letters|May 16, 2002
Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insultsHirohisa Tajima, Takako Niikura, Yuichi Hashimoto, et al.
Biological Chemistry|May 20, 2003
Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsetsAlicja Bukowska, Janine Tadje, Marco Arndt, et al.
Organic & Biomolecular Chemistry|December 17, 2020
<i>meta</i>-Non-flat substituents: a novel molecular design to improve aqueous solubility in small molecule drug discoveryYuki Ichikawa, Michiaki Hiramatsu, Yusuke Mita, et al.
Bioorganic & Medicinal Chemistry|May 29, 2007
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonistsJun-Ichi Kasuga, Izumi Nakagome, Atsushi Aoyama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2009
[Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity]Jun-Ichi Kasuga, Takuji Oyama, Izumi Nakagome, et al.
Journal of Medicinal Chemistry|April 14, 2006
Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesisYusuke Nakano, Yuko Kato, Keisuke Imai, et al.
Pageof 28

Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|April 18, 2006
Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligandsMasahiko Kainuma, Jun-ichi Kasuga, Shinnosuke Hosoda, et al.
The European Journal of Neuroscience|April 3, 2003
A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insultsTakako Niikura, Yuichi Hashimoto, Hirohisa Tajima, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 4, 2005
Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivoTomohiro Chiba, Marina Yamada, Yuichi Hashimoto, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationshipMasao Ohashi, Takuji Oyama, Izumi Nakagome, et al.
Neuroscience Letters|May 16, 2002
Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insultsHirohisa Tajima, Takako Niikura, Yuichi Hashimoto, et al.
Biological Chemistry|May 20, 2003
Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsetsAlicja Bukowska, Janine Tadje, Marco Arndt, et al.
Organic & Biomolecular Chemistry|December 17, 2020
<i>meta</i>-Non-flat substituents: a novel molecular design to improve aqueous solubility in small molecule drug discoveryYuki Ichikawa, Michiaki Hiramatsu, Yusuke Mita, et al.
Bioorganic & Medicinal Chemistry|May 29, 2007
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonistsJun-Ichi Kasuga, Izumi Nakagome, Atsushi Aoyama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2009
[Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity]Jun-Ichi Kasuga, Takuji Oyama, Izumi Nakagome, et al.
Journal of Medicinal Chemistry|April 14, 2006
Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesisYusuke Nakano, Yuko Kato, Keisuke Imai, et al.
Pageof 28